NCT06980077
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06980077
Title Ivonescimab for the Treatment of Thymic Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Jonsson Comprehensive Cancer Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of California at Davis (UCD) NOT_YET_RECRUITING Davis California 95817 United States Details
University of California at Irvine (UCI) NOT_YET_RECRUITING Irvine California 92868 United States Details
UCLA / Jonsson Comprehensive Cancer Center RECRUITING Los Angeles California 90095 United States Details
University of California at San Francisco (UCSF) RECRUITING San Francisco California 94115 United States Details
Dana Farber Cancer Institute NOT_YET_RECRUITING Boston Massachusetts 02115 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field